European Stroke Prevention Study 2. Efficacy and safety data

J Neurol Sci. 1997 Sep:151 Suppl:S1-77. doi: 10.1016/s0022-510x(97)86566-5.
No abstract available

Publication types

  • Clinical Trial
  • Controlled Clinical Trial
  • Multicenter Study

MeSH terms

  • Aged
  • Aspirin / administration & dosage*
  • Aspirin / adverse effects
  • Cerebrovascular Disorders / drug therapy*
  • Cerebrovascular Disorders / mortality
  • Cerebrovascular Disorders / prevention & control*
  • Data Interpretation, Statistical
  • Delayed-Action Preparations
  • Dipyridamole / administration & dosage*
  • Dipyridamole / adverse effects
  • Double-Blind Method
  • Female
  • Humans
  • Male
  • Middle Aged
  • Patient Compliance
  • Placebos
  • Platelet Aggregation Inhibitors / administration & dosage*
  • Platelet Aggregation Inhibitors / adverse effects
  • Safety

Substances

  • Delayed-Action Preparations
  • Placebos
  • Platelet Aggregation Inhibitors
  • Dipyridamole
  • Aspirin